Abstract
Background
Simkania negevensis is an obligate intracellular Gram-negative bacterium (family Simkaniaceae, order Chlamydiales) that has been isolated from domestic and mains water supplies, is able to infect human macrophages, and can induce an inflammatory response in the host.
Methods
From June to December 2016, in a single-center observational study, colonic Crohn’s disease patients and controls (subjects undergoing screening for colorectal cancer) underwent blood tests to identify serum-specific immunoglobulin G (IgG) and immunoglobulin A (IgA) to S. negevensis and a colonoscopy with biopsies for detection of S. negevensis DNA by polymerase chain reaction (PCR).
Results
Forty-three Crohn’s disease patients and 18 controls were enrolled. Crohn’s disease patients had higher prevalence of IgA antibodies to S. negevensis compared with controls (20.9% versus 0%, p = 0.04). Simkaniaceae negevensis DNA was detected in 34.9% and 5.6% of intestinal biopsies in Crohn’s disease patients and controls, respectively (p = 0.02). All Crohn’s disease patients with PCR-positive biopsies for S. negevensis were IgG seropositive, with specific IgA in 60% of them (p < 0.001). Immunosuppressive therapies, extraintestinal manifestations, or disease activity did not influence the presence of S. negevensis in the Crohn’s disease population.
Conclusions
We identified S. negevensis in Crohn’s disease patients by demonstrating the presence of S. negevensis mucosal DNA and seropositivity to the bacterium. These results could support the presence of an acute or persistent S. negevensis infection and suggest a possible role in the pathogenesis of Crohn’s disease.
Similar content being viewed by others
References
Liverani E, Scaioli E, Cardamone C, et al. Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? World J Gastroenterol. 2014;20:13060–13070.
Buisson A, Bringer MA, Barnich N, et al. Macrophages versus Escherichia coli: a decisive fight in Crohn’s disease. Inflamm Bowel Dis. 2016;22:2943–2955.
Kahane S, Gonen R, Sayada C, et al. Description and partial characterization of a new Chlamydia-like microorganism. FEMS Microbiol Lett. 1993;109:329–333.
Kahane S, Dvoskin B, Mathias M, et al. Infection of Acanthamoeba polyphaga with Simkania negevensis and S. negevensis survival within amoebal cysts. Appl Environ Microbiol. 2001;67:4789–4795.
Kahane S, Platzner N, Dvoskin B, et al. Evidence for the presence of Simkania negevensis in drinking water and in reclaimed wastewater in Israel. Appl Environ Microbiol. 2004;70:3346–3351.
Donati M, Cremonini E, Di Francesco A, et al. Prevalence of Simkania negevensis in chlorinated water from spa swimming pools and domestic supplies. J Appl Microbiol. 2015;118:1076–1082.
Casson N, Greub G. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes. Int J Antimicrob Agents. 2006;27:541–544.
Kahane S, Fruchter D, Dvoskin B, et al. Versatility of Simkania negevensis infection in vitro and induction of host cell inflammatory cytokine response. J Infect. 2007;55:e13–e21.
Kahane S, Dvoskin B, Friedman MG. The role of monocyte/macrophages as vehicles of dissemination of Simkania negevensis: an in vitro simulation model. FEMS Immunol Med Microbiol. 2008;52:219–227.
Herweg JA, Rudel T. Interaction of Chlamydiae with human macrophages. FEBS J. 2016;283:608–618.
Kahane S, Greenberg D, Friedman MG, et al. High prevalence of ‘Simkania Z’, a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis. 1998;177:1425–1429.
Lieberman D, Dvoskin B, Lieberman DV, et al. Serological evidence of acute infection with the Chlamydia-like microorganism Simkania negevensis (Z) in acute exacerbation of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis. 2002;21:307–309.
Fasoli L, Paldanius M, Don M, et al. Simkania negevensis in community-acquired pneumonia in Italian children. Scand J Infect Dis. 2008;40:269–272.
Donati M, Fiani N, Di Francesco A, et al. IgG and IgA response to Simkania negevensis in sera of patients with respiratory and gastrointestinal symptoms. New Microbiologica. 2013;36:303–306.
Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–444.
Petersen BT, Chennat J, Cohen J, et al. Multisociety guideline on reprocessing flexible gastrointestinal endoscopes, 2011. Gastrointest Endosc. 2011;73:1075–1368.
Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60:505–512.
Donati M, Di Paolo M, Avanzi S, et al. Detection of Simkania negevensis in cell culture by using a monoclonal antibody. New Microbiol. 2013;36:85–88.
Fukushi H, Hirai K. Immunochemical diversity of the major outer membrane protein of avian and mammalian Chlamydia psittaci. J Clin Microbiol. 1988;26:675–680.
Friedman MG, Galli A, Greenberg S, et al. Seroprevalence of IgG antibodies to the chlamydia-like microorganism “Simkania Z” by ELISA. Epidemiol Infect. 1999;122:117–123.
Petrich A, Smieja M, Luinstra K, et al. Development of a PCR assay to determine prevalence of Simkania negevensis DNA in specimens from patients with respiratory diseases. In: Chlamydial infections. Proceedings of the Tenth International Symposium on Human Chlamydial infections ed. Schachter. San Francisco, USA; 2002.
Vouga M, Baud D, Greub G. Simkania negevensis, an insight into the biology and clinical importance of a novel member of the Chlamydiales order. Crit Rev Microbiol. 2017;43:62–80.
Gordon SB, Read RC. Macrophage defences against respiratory tract infections. Br Med Bull. 2002;61:45–46.
Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12:814–822.
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27–42.
Hugot JP, Chamaillard M, Zouali H, et al. Association of nod2leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.
Homer CR, Richmond AL, Rebert NA, et al. Atg16l1 and nod2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn’s disease pathogenesis. Gastroenterology. 2010;139:1630–1641.
Müller S, Arni S, Varga L, et al. Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2006;18:889–894.
Chen W, Li D, Wilson I, et al. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls. J Gastroenterol Hepatol. 2002;17:987–993.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Scaioli, E., Biondi, R., Liverani, E. et al. Simkania negevensis in Crohn’s Disease. Dig Dis Sci 64, 3284–3290 (2019). https://doi.org/10.1007/s10620-019-05632-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-05632-4